Literature DB >> 8132755

Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.

J Kusari1, K A Kenner, K I Suh, D E Hill, R R Henry.   

Abstract

Particulate and cytosolic protein tyrosine phosphatase (PTPase) activity was measured in skeletal muscle from 15 insulin-sensitive subjects and 5 insulin-resistant nondiabetic subjects, as well as 18 subjects with non-insulin-dependent diabetes mellitus (NIDDM). Approximately 90% of total PTPase activity resided in the particulate fraction. In comparison with lean nondiabetic subjects, particulate PTPase activity was reduced 21% (P < 0.05) and 22% (P < 0.005) in obese nondiabetic and NIDDM subjects, respectively. PTPase1B protein levels were likewise decreased by 38% in NIDDM subjects (P < 0.05). During hyperinsulinemic glucose clamps, glucose disposal rates (GDR) increased approximately sixfold in lean control and twofold in NIDDM subjects, while particulate PTPase activity did not change. However, a strong positive correlation (r = 0.64, P < 0.001) existed between particulate PTPase activity and insulin-stimulated GDR. In five obese NIDDM subjects, weight loss of approximately 10% body wt resulted in a significant and corresponding increase in both particulate PTPase activity and insulin-stimulated GDR. These findings indicate that skeletal muscle particulate PTPase activity and PTPase1B protein content reflect in vivo insulin sensitivity and are reduced in insulin resistant states. We conclude that skeletal muscle PTPase activity is involved in the chronic, but not acute regulation of insulin action, and that the decreased enzyme activity may have a role in the insulin resistance of obesity and NIDDM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132755      PMCID: PMC294066          DOI: 10.1172/JCI117068

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

Review 4.  Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus.

Authors:  J A Truglia; J N Livingston; D H Lockwood
Journal:  Am J Med       Date:  1985-08-23       Impact factor: 4.965

5.  Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus.

Authors:  R R Henry; P Wallace; J M Olefsky
Journal:  Diabetes       Date:  1986-09       Impact factor: 9.461

6.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.

Authors:  J F Caro; O Ittoop; W J Pories; D Meelheim; E G Flickinger; F Thomas; M Jenquin; J F Silverman; P G Khazanie; M K Sinha
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

7.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.

Authors:  G R Freidenberg; R R Henry; H H Klein; D R Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

8.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Organic extraction of Pi with isobutanol/toluene.

Authors:  E Shacter
Journal:  Anal Biochem       Date:  1984-05-01       Impact factor: 3.365

10.  Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats.

Authors:  S Hauguel-de Mouzon; P Peraldi; F Alengrin; E Van Obberghen
Journal:  Endocrinology       Date:  1993-01       Impact factor: 4.736

View more
  26 in total

1.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Authors:  Z Y Jiang; Y W Lin; A Clemont; E P Feener; K D Hein; M Igarashi; T Yamauchi; M F White; G L King
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

3.  Structure-based prediction of free energy changes of binding of PTP1B inhibitors.

Authors:  Jing Wang; Shek Ling Chan; Kal Ramnarayan
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

4.  An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.

Authors:  Zhong Q Wang; David Ribnicky; Xian H Zhang; Aamir Zuberi; Ilya Raskin; Yongmei Yu; William T Cefalu
Journal:  J Nutr Biochem       Date:  2010-05-05       Impact factor: 6.048

5.  Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.

Authors:  Yong Wu; Jing Ping Ouyang; Ke Wu; Shi Shun Wang; Chong Yuan Wen; Zheng Yuan Xia
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 6.  Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.

Authors:  J C Byon; A B Kusari; J Kusari
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Authors:  F Ahmad; J L Azevedo; R Cortright; G L Dohm; B J Goldstein
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

8.  Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.

Authors:  A Sorokin; E Reed
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.

Authors:  Janice M Zabolotny; Young-Bum Kim; Laura A Welsh; Erin E Kershaw; Benjamin G Neel; Barbara B Kahn
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

10.  Ventromedial hypothalamus-specific Ptpn1 deletion exacerbates diet-induced obesity in female mice.

Authors:  Franck Chiappini; Karyn J Catalano; Jennifer Lee; Odile D Peroni; Jacqueline Lynch; Abha S Dhaneshwar; Kerry Wellenstein; Alexandra Sontheimer; Benjamin G Neel; Barbara B Kahn
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.